SCHEMBL4124662

SCHEMBL4124662

COc1cccc(C(=O)c2cc(Cl)ccc2N)c1C

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.56
RORC P51449 3/20 0.49
RORB Q92753 3/20 0.49
FADS1 O60427 1/20 0.45
UTS2R Q9UKP6 2/20 0.44
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
ABL1 P00519 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 1/20 0.43
KCNMA1 Q12791 1/20 0.43
HIF1A Q16665 1/20 0.43
NOS2 P35228 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4125266 0.87 RECQL (0.57) RECQLRORCRORBFADS1MAPK13
SCHEMBL2705425 0.87 RECQL (0.65) RECQLRORCRORBMAPK13MAPK12
SCHEMBL4132207 0.86 RECQL (0.56) RECQLRORCRORBFADS1MAPK13
SCHEMBL635552 0.86 RECQL (0.56) RECQLRORCRORBFADS1MAPK13
SCHEMBL15641368 0.85 RECQL (0.55) RECQLRORCRORBFADS1MAPK13
SCHEMBL4126866 0.84 KEAP1 (0.49) FADS1MAPK14LMNA
SCHEMBL4115238 0.83 RECQL (0.52) RECQLRORCRORBFADS1MAPK13
SCHEMBL4117580 0.83 RECQL (0.52) RECQLRORCRORBFADS1MAPK13
SCHEMBL14146205 0.81 RECQL (0.60) RECQLFADS1KDM4EALDH1A1NOS2
SCHEMBL4124299 0.81 RECQL (0.50) RECQLRORCRORBKCNMA1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR RECQL 271/4885RORC 2588/4885RORB 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.